(NASDAQ: DTIL) Precision Biosciences's forecast annual revenue growth rate of 4.17% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Precision Biosciences's revenue in 2025 is $68,696,000.On average, 1 Wall Street analysts forecast DTIL's revenue for 2025 to be $477,976,054, with the lowest DTIL revenue forecast at $477,976,054, and the highest DTIL revenue forecast at $477,976,054. On average, 1 Wall Street analysts forecast DTIL's revenue for 2026 to be $697,048,412, with the lowest DTIL revenue forecast at $697,048,412, and the highest DTIL revenue forecast at $697,048,412.
In 2027, DTIL is forecast to generate $793,482,177 in revenue, with the lowest revenue forecast at $793,482,177 and the highest revenue forecast at $793,482,177.